Revenue (GAAP) increased 11.1% to $6.0 billion, above analyst expectations. Adjusted earnings per share rose 11.4% to $3.13, exceeding consensus estimates. Full-year 2025 guidance was raised for both ...

Read more about Gordon Longhorns multi-sport star Stryker Reed after the senior announced his verbal commitment to play ...

Stryker Corp (($SYK)) has held its Q2 earnings call. Read on for the main highlights of the call. Stryker Corp’s recent earnings call reflected a ...

The medtech firm, which previously forecast a $200 million tariff impact for 2025, also raised its earnings outlook, citing ...

Stryker reached a key milestone with its Mako robotics, Jason Beach, vice president of finance and investor relations, said in a July 31 earnings call. During the second quarter Stryker reached 2 ...

Stryker remains a top-tier competitor in a number of attractive medical markets, including orthopedic implants, surgical instruments, endoscopy, and neurovascular devices. It enjoys a long record of ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $429.5, a high estimate of $455.00, and a low estimate of $400.00. Marking an increase of 3.18%, the ...

Stryker Corp (SYK) reports robust sales and EPS growth, raises full-year guidance despite ongoing supply chain issues.

Stryker (SYK) just dropped its Q2 2025 earnings, and spoiler alert: they smashed expectations with an EPS of $3.13 (beating forecasts by 1.95%) and revenue hitting $6.02 billion. Organic sales spiked ...

The long-awaited announcement of Gordon’s star athlete was made Thursday as Stryker Reed committed to Air Force to continue his multi-sport career with football and track and field on Dave Campbell’s ...

Stryker Corporation reports strong Q2 2025 growth with 10.2% organic sales increase, raised full-year guidance, and booming Mako robotic installations.

Medical technology company Stryker (NYSE:SYK) reported Q2 CY2025 results topping the market’s revenue expectations, with ...